| Abstract [eng] |
Approach in assessing the Lithuaninan Pharmaceutical Business Environment Ratings is threefold. First, was defined the risks rated to capture the operational dangers to companies operating in this industry. Second, was attempt where possible to identify objective indicators that may serve as proxies for issues/trends. Finally country risk ratings is used to ensure only the aspects most relevant to the industry are included. Overall, the system, offers an industry-leading insight into the prospects/risks for companies across the globe. Limits of potential returns: Evaluation of sector’s size and growth potential in each state, and also broader industry/state characteristics that may inhibit its development. Risks to realisation of those returns: Evaluation of industry-specific dangers and those emanating from the state’s political/economic profile that call into question the likelihood of anticipated returns being realised over the assessed time period. |
